STATCenter·
STAT+: Roche gets a lung cancer win with its KRAS drug divarasib
One of the more impressive data sets at this year’s ESMO came from a Roche study of its drug divarasib, which treats lung cancer.
Read at STAT →
Health · 1 sources covering this
STAT+: Roche gets a lung cancer win with its KRAS drug divarasib
One of the more impressive data sets at this year’s ESMO came from a Roche study of its drug divarasib, which treats lung cancer.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/454151f6c1c281c80273bcf43988b4caa7cd89f0" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: Roche gets a lung cancer win with its KRAS drug divarasib"></iframe>
